Valbiotis

Description: Valbiotis develops Valedia, a Phase II clinical trial product for type 2 diabetes, and nutrition solutions to combat metabolic diseases.

Country: France

Based in: La Rochelle

Founded: 2014

Funding Stage: Series A/B

Tags: ['Biotechnology', 'Hospital', 'Medical']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.